# Appropriate referral and selection of patients with chronic pain for spinal cord stimulation: European consensus recommendations and e‐health tool

**Authors:** Simon Thomson, Frank Huygen, Simon Prangnell, José De Andrés, Ganesan Baranidharan, Hayat Belaïd, Neil Berry, Bart Billet, Jan Cooil, Giuliano De Carolis, Laura Demartini, Sam Eldabe, Kliment Gatzinsky, Jan W. Kallewaard, Kaare Meier, Mery Paroli, Angela Stark, Matthias Winkelmüller, Herman Stoevelaar

PMC · DOI: 10.1002/ejp.1562 · European Journal of Pain (London, England) · 2020-04-04

## TL;DR

This paper presents European consensus recommendations and an e-health tool to help doctors decide which chronic pain patients are suitable for spinal cord stimulation treatment.

## Contribution

The paper introduces a multidisciplinary consensus-based framework and an e-health tool integrating clinical and psychosocial factors for spinal cord stimulation selection.

## Key findings

- Appropriateness of spinal cord stimulation is strongly influenced by neuropathic pain characteristics and prior treatment responses.
- Psychosocial factors like dysfunctional coping and unrealistic expectations are critical in determining eligibility for SCS.
- An e-health tool was developed to guide clinicians in applying these criteria for patient selection.

## Abstract

Spinal cord stimulation (SCS) is an established treatment for chronic neuropathic, neuropathic‐like and ischaemic pain. However, the heterogeneity of patients in daily clinical practice makes it often challenging to determine which patients are eligible for this treatment, resulting in undesirable practice variations. This study aimed to establish patient‐specific recommendations for referral and selection of SCS in chronic pain.

A multidisciplinary European panel used the RAND/UCLA Appropriateness Method (RUAM) to assess the appropriateness of (referral for) SCS for 386 clinical scenarios in four pain areas: chronic low back pain and/or leg pain, complex regional pain syndrome, neuropathic pain syndromes and ischaemic pain syndromes. In addition, the panel identified a set of psychosocial factors that are relevant to the decision for SCS treatment.

Appropriateness of SCS was strongly determined by the neuropathic or neuropathic‐like pain component, location and spread of pain, anatomic abnormalities and previous response to therapies targeting pain processing (e.g. nerve block). Psychosocial factors considered relevant for SCS selection were as follows: lack of engagement, dysfunctional coping, unrealistic expectations, inadequate daily activity level, problematic social support, secondary gain, psychological distress and unwillingness to reduce high‐dose opioids. An educational e‐health tool was developed that combines clinical and psychosocial factors into an advice on referral/selection for SCS.

The RUAM was useful to establish a consensus on patient‐specific criteria for referral/selection for SCS in chronic pain. The e‐health tool may help physicians learn to apply an integrated approach of clinical and psychosocial factors.

Determining the eligibility of SCS in patients with chronic pain requires careful consideration of a variety of clinical and psychosocial factors. Using a systematic approach to combine evidence from clinical studies and expert opinion, a multidisciplinary European expert panel developed detailed recommendations to support appropriate referral and selection for SCS in chronic pain. These recommendations are available as an educational e‐health tool (https://www.scstool.org/).

## Full-text entities

- **Genes:** LMX1B (LIM homeobox transcription factor 1 beta) [NCBI Gene 4010] {aka FSGS10, LMX1.2, NPS1}
- **Diseases:** anatomic abnormality (MESH:D020763), disturbances (MESH:D014832), ischaemic (MESH:D018917), Chronic low back and leg pain (MESH:D059350), CRPS (MESH:D020918), Pain (MESH:D010146), brachial plexus injury (MESH:D020516), SCS (MESH:D013118), postherpetic neuralgia (MESH:D051474), Spinal instability (MESH:D043171), movement (MESH:D009069), low back and/or leg pain (MESH:D017116), mono- and polyneuropathies (MESH:D011115), gangrene (MESH:D005734), foraminal stenosis (MESH:D003251), critical limb ischaemia (MESH:D000089802), Raynaud's disease (MESH:D011928), block (MESH:D006327), psychological or psychiatric disorderOngoing (MESH:D001523), small fibre neuropathy (MESH:D000071075), Psychological distress (MESH:D012128), amputation (MESH:C565682), abnormality (MESH:D000014), Buerger's disease (MESH:D013919), disc (MESH:D055959), low mood (MESH:D019964), back pain (MESH:D001416), nociceptive (MESH:D059226), vasomotor disturbances (MESH:D012223), post-chemotherapy neuropathy (MESH:D000084202), diabetic polyneuropathy (MESH:D003929), spinal/foraminal stenosis (MESH:D013130), ischaemic ulcers (MESH:D014456), Diabetic peripheral neuropathy (MESH:D010523), failed back surgery syndrome (MESH:D055111), mental health problems (MESH:D000076082), panic disorder (MESH:D016584), IPS 1 (MESH:C538101), root avulsion (MESH:D011843), spine infection (MESH:D007239), post-surgical pain (MESH:D010149), Iatrogenic nerve lesion (MESH:D007049), nerve damage (MESH:D000080902), phantom and stump pain (MESH:D010591), substance abuse (MESH:D019966), ischemia (MESH:D007511), neuropathic and (MESH:D009437), mononeuritis (MESH:D020422), Dysfunctional coping (MESH:D006331), anxiety (MESH:D001007), autonomic (MESH:D001342), post-traumatic stress disorder (MESH:D013313), coagulation disorder (MESH:D001778), nerve lesion (MESH:D020426), Refractory angina pectoris (MESH:D000787), Fontaine II-III (MESH:C536311), Fontaine III-IV (MESH:D006011), sensory disturbances (MESH:D012678)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC7318692/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC7318692/full.md

## References

50 references — full list in the complete paper: https://tomesphere.com/paper/PMC7318692/full.md

---
Source: https://tomesphere.com/paper/PMC7318692